elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Trastuzumab
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Trastuzumab
RIS
0.001
(Research Intensity Score)
Papers
130
Top papers
MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases
2021 · 226 citations
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02
2025 · 7 citations
Antibody–Drug Conjugates and Beyond: Next-Generation Targeted Therapies for Breast Cancer
2025 · 6 citations
Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate
2024 · 13 citations
Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles
2023 · 30 citations
JSKN003, a biparatopic anti-HER2 antibody drug conjugate (ADC), in the treatment of platinum-resistant ovarian cancer (PROC): Updated findings from two clinical trials.
2025 · 8 citations
Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial
2025 · 10 citations
Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach
2025 · 5 citations
Evaluation of [ 89 Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer
2023 · 28 citations
Newest papers
Paclitaxel liposome with anti–HER-2 drugs as first-line therapy for recurrent/metastatic HER-2–positive breast cancer: a real-world study
2026
Case Report: Successful trastuzumab deruxtecan rechallenge after disease progression in a pretreated HER2-mutated lung adenocarcinoma patient
2026
Đánh giá chức năng thất trái bằng siêu âm tim 3D và siêu âm tim đánh dấu mô ở người bệnh ung thư vú sau điều trị với anthracycline và trastuzumab
2026
Efficacy and safety of brain radiotherapy combined with antibody-drug conjugates in patients with HER2-positive breast cancer brain metastases
2026
Beyond the left ventricle: CMR assessment of right ventricular dysfunction during cancer therapy
2026
Application of HER2-Targeted Antibody-Drug Conjugates in the Treatment of Gastric Cancer: A Systematic Review of Pivotal Clinical Evidence
2026
Next-Generation Anticancer Modalities: A Systematic Review of Antibody–Drug Conjugates, Bispecific Antibodies, CAR-T Cell Therapy, Cancer Vaccines, and Radioligand Therapy
2026
Intracellular Nanopharmacology of Trastuzumab Deruxtecan Reveals Lysosome-Centered Organelle Vulnerabilities in HER2-Positive Breast Cancer Cells
2026
Industry Insights: Bioconjugate momentum builds with wave of regulatory approvals, clinical advances, and conference data disclosures
2026
Browse all papers →
Trastuzumab's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Trastuzumab's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link